Carl D. Regillo, MD, FACS, FASRS, discusses geographic atrophy, the advanced stage of dry age-related macular degeneration, including its diagnosis, and progression.
Ocugen announces positive preliminary data from OCU410 Phase 1 clinical trial for geographic atrophy
Spotlighting telemedicine in the year of a pandemic
New treatment options provide effective management of geographic atrophy
Merger of Akari Therapeutics, Plc and Peak Bio, Inc. is complete
Identifying and monitoring GA: Technologic improvements over time
New data on PST-611 from PulseSight Therapeutics SAS shared at EVER Congress 2024